• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钆塞酸增强肝脏磁共振成像与多排 CT 在检测肝内不典型增生结节和早期肝细胞癌中的诊断性能比较。

Diagnostic Performance of Gadoxetic Acid-enhanced Liver MR Imaging versus Multidetector CT in the Detection of Dysplastic Nodules and Early Hepatocellular Carcinoma.

机构信息

From the Department of Radiology (B.R.K., J.M.L., D.H.L., J.H.Y., J.K.H.), Institute of Radiation Medicine (J.M.L., J.K.H.), Department of General Surgery (K.S.S., N.J.Y.), and Department of Pathology (K.B.L.), Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul 110-744, Korea; and Department of Radiology, National Cancer Center, Seoul, Korea (B.Y.H.).

出版信息

Radiology. 2017 Oct;285(1):134-146. doi: 10.1148/radiol.2017162080. Epub 2017 Jun 13.

DOI:10.1148/radiol.2017162080
PMID:28609205
Abstract

Purpose To compare the diagnostic performance of gadoxetic acid-enhanced liver magnetic resonance (MR) imaging with that of contrast material-enhanced multidetector computed tomography (CT) in the detection of borderline hepatocellular nodules in patients with liver cirrhosis and to determine the Liver Imaging Reporting and Data System (LI-RADS) categories of these detected nodules. Materials and Methods The institutional review board approved this retrospective study and waived the informed consent requirement. Sixty-eight patients with pathologically proven dysplastic nodules (DNs) (low-grade DNs, n = 20; high-grade DNs, n = 17), early hepatocellular carcinomas (HCCs) (n = 42), or progressed HCCs (n = 33) underwent gadoxetic acid-enhanced MR imaging and multidetector CT. An additional 57 patients without any DNs or HCCs in the explanted livers were included as control subjects. Three radiologists independently graded the presence of liver nodules on a five-point confidence scale and assigned LI-RADS categories by using imaging findings. Jackknife alternative free-response receiver operating characteristics (JAFROC) software was used to compare the diagnostic accuracy of each modality in lesion detection. Results Reader-averaged figures of merit estimated with JAFROC software to detect hepatocellular nodules were 0.774 for multidetector CT and 0.842 for MR imaging (P = .002). Readers had significantly higher detection sensitivity for early HCCs with MR imaging than with multidetector CT (78.6% vs 52.4% [P = .001], 71.4% vs 50.0% [P = .011], and 73.8% vs 50.0% [P = .001], respectively). A high proportion of overall detected early HCCs at multidetector CT (59.4%) and MR imaging (72.3%) were categorized as LI-RADS category 4. Most early HCCs (76.2%) and high-grade DNs (82.4%) demonstrated hypointensity on hepatobiliary phase images. In total, 30 more LI-RADS category 4 early HCCs were identified with MR imaging than with multidetector CT across all readers. Conclusion Gadoxetic acid-enhanced MR imaging performed significantly better in the detection of high-risk borderline nodules, especially early HCCs, than did multidetector CT. RSNA, 2017 Online supplemental material is available for this article.

摘要

目的

比较钆塞酸增强肝脏磁共振成像(MR)与多排 CT 对比增强在肝硬化患者边界性肝细胞结节检测中的诊断性能,并确定这些检测结节的肝脏成像报告和数据系统(LI-RADS)分类。

材料与方法

本回顾性研究经机构审查委员会批准,并豁免了知情同意书的要求。68 例经病理证实为异型增生结节(DN)(低级别 DN,20 例;高级别 DN,17 例)、早期肝细胞癌(HCC)(42 例)或进展性 HCC(33 例)患者接受了钆塞酸增强 MR 成像和多排 CT 检查。另外,57 例在肝切除标本中无任何 DN 或 HCC 的患者作为对照。3 名放射科医生独立地对 5 分置信度量表上的肝脏结节存在情况进行分级,并根据影像学表现对 LI-RADS 类别进行赋值。使用 Jackknife alternative free-response receiver operating characteristics(JAFROC)软件比较每种方法在检测病变中的诊断准确性。

结果

使用 JAFROC 软件估计,多排 CT 和 MR 成像检测肝细胞结节的读者平均特征值分别为 0.774 和 0.842(P =.002)。与多排 CT 相比,MR 成像对早期 HCC 的检测敏感性显著更高(78.6%比 52.4%[P =.001],71.4%比 50.0%[P =.011],73.8%比 50.0%[P =.001])。多排 CT(59.4%)和 MR 成像(72.3%)检测到的大多数早期 HCC 均归类为 LI-RADS 类别 4。大多数早期 HCC(76.2%)和高级别 DN(82.4%)在肝胆期图像上呈低信号。在所有读者中,MR 成像共检出 30 例多排 CT 漏诊的 LI-RADS 类别 4 早期 HCC。

结论

与多排 CT 相比,钆塞酸增强 MR 成像在检测高危边界性结节(尤其是早期 HCC)方面表现出更好的性能。

相似文献

1
Diagnostic Performance of Gadoxetic Acid-enhanced Liver MR Imaging versus Multidetector CT in the Detection of Dysplastic Nodules and Early Hepatocellular Carcinoma.钆塞酸增强肝脏磁共振成像与多排 CT 在检测肝内不典型增生结节和早期肝细胞癌中的诊断性能比较。
Radiology. 2017 Oct;285(1):134-146. doi: 10.1148/radiol.2017162080. Epub 2017 Jun 13.
2
Diagnostic performance of gadoxetic acid-enhanced liver MR imaging in the detection of HCCs and allocation of transplant recipients on the basis of the Milan criteria and UNOS guidelines: correlation with histopathologic findings.钆塞酸增强肝脏磁共振成像在检测 HCC 和根据米兰标准和 UNOS 指南分配肝移植受者中的诊断性能:与组织病理学发现的相关性。
Radiology. 2015 Jan;274(1):149-60. doi: 10.1148/radiol.14140141. Epub 2014 Sep 5.
3
Imaging study of early hepatocellular carcinoma: usefulness of gadoxetic acid-enhanced MR imaging.早期肝细胞癌的影像学研究:钆塞酸增强磁共振成像的作用。
Radiology. 2011 Dec;261(3):834-44. doi: 10.1148/radiol.11101840. Epub 2011 Oct 13.
4
Diagnostic accuracy of gadoxetic acid-enhanced MR for small hypervascular hepatocellular carcinoma and the concordance rate of Liver Imaging Reporting and Data System (LI-RADS).钆塞酸二钠增强磁共振成像对小的富血供肝细胞癌的诊断准确性及肝脏影像报告和数据系统(LI-RADS)的符合率
PLoS One. 2017 May 30;12(5):e0178495. doi: 10.1371/journal.pone.0178495. eCollection 2017.
5
Small (≤1-cm) hepatocellular carcinoma: diagnostic performance and imaging features at gadoxetic acid-enhanced MR imaging.小肝癌(≤1cm):钆塞酸增强磁共振成像的诊断性能和影像学特征。
Radiology. 2014 Jun;271(3):748-60. doi: 10.1148/radiol.14131996. Epub 2014 Feb 1.
6
Radiologic-Pathologic Correlation of Hepatobiliary Phase Hypointense Nodules without Arterial Phase Hyperenhancement at Gadoxetic Acid-enhanced MRI: A Multicenter Study.钆塞酸增强 MRI 肝胆期低信号结节无动脉期强化的放射-病理对照:多中心研究。
Radiology. 2020 Aug;296(2):335-345. doi: 10.1148/radiol.2020192275. Epub 2020 Jun 2.
7
Liver imaging reporting and data system v2014 categorization of hepatocellular carcinoma on gadoxetic acid-enhanced MRI: Comparison with multiphasic multidetector computed tomography.肝脏影像报告和数据系统(LI-RADS)v2014对钆塞酸二钠增强MRI上肝细胞癌的分类:与多期多层螺旋CT的比较
J Magn Reson Imaging. 2017 Mar;45(3):731-740. doi: 10.1002/jmri.25406. Epub 2016 Jul 30.
8
Liver Imaging Reporting and Data System with MR Imaging: Evaluation in Nodules 20 mm or Smaller Detected in Cirrhosis at Screening US.肝脏影像报告和数据系统与磁共振成像:在筛查 US 中检测到肝硬化中 20mm 或更小的结节的评估。
Radiology. 2015 Jun;275(3):698-707. doi: 10.1148/radiol.15141132. Epub 2015 Feb 5.
9
Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.钆塞酸增强肝胆期 MRI 和高 b 值扩散加权成像在慢性肝病患者中鉴别高分化肝细胞癌与良性结节
AJR Am J Roentgenol. 2011 Nov;197(5):W868-75. doi: 10.2214/AJR.10.6237.
10
Nonhypervascular Hypointense Nodules at Gadoxetic Acid-enhanced MR Imaging in Chronic Liver Disease: Diffusion-weighted Imaging for Characterization.慢性肝病患者钆塞酸增强磁共振成像中无强化低信号结节:弥散加权成像的特征分析。
Radiology. 2015 Jul;276(1):137-46. doi: 10.1148/radiol.15141350. Epub 2015 Feb 27.

引用本文的文献

1
Gadoxetic acid-enhanced MRI in hepatocellular carcinoma: a comprehensive review of diagnostic, surveillance, and treatment response prediction and assessment.钆塞酸二钠增强磁共振成像在肝细胞癌中的应用:诊断、监测及治疗反应预测与评估的全面综述
Jpn J Radiol. 2025 Sep 15. doi: 10.1007/s11604-025-01870-x.
2
Long-term outcomes of indeterminate focal hepatic observations less than 20 mm followed up with gadoxetic acid-enhanced magnetic resonance imaging (Gd-EOB-DTPA-MRI).钆塞酸二钠增强磁共振成像(Gd-EOB-DTPA-MRI)随访观察小于20mm的肝脏局灶性病变的长期结果
J Gastrointest Oncol. 2025 Jun 30;16(3):1078-1091. doi: 10.21037/jgo-2025-302. Epub 2025 Jun 27.
3
Common pitfalls and diagnostic challenges in the application of LI-RADS CT/MRI algorithms: a comprehensive review.
LI-RADS CT/MRI算法应用中的常见陷阱与诊断挑战:全面综述
Abdom Radiol (NY). 2024 Dec 24. doi: 10.1007/s00261-024-04778-8.
4
Value of magnetic resonance imaging for diagnosis of LR‑3 and LR-4 lesions coexisting with hepatocellular carcinoma.磁共振成像对合并肝细胞癌的 LR-3 和 LR-4 病变的诊断价值。
Abdom Radiol (NY). 2024 Aug;49(8):2629-2638. doi: 10.1007/s00261-024-04338-0. Epub 2024 Jun 5.
5
Performance of LI-RADS category 5 vs combined categories 4 and 5: a systemic review and meta-analysis.LI-RADS 类别 5 与类别 4 和 5 联合的表现:系统评价和荟萃分析。
Eur Radiol. 2024 Nov;34(11):7025-7040. doi: 10.1007/s00330-024-10813-5. Epub 2024 May 29.
6
The comparison of contrast-enhanced ultrasound and gadoxetate disodium-enhanced MRI LI-RADS for nodules ≤2 cm in patients at high risk for HCC: a prospective study.超声造影与钆塞酸二钠增强MRI LI-RADS对肝癌高危患者≤2 cm结节的比较:一项前瞻性研究。
Front Oncol. 2024 May 7;14:1345981. doi: 10.3389/fonc.2024.1345981. eCollection 2024.
7
CT texture features and lung shunt fraction measured using Tc-macroaggregated albumin SPECT/CT before trans-arterial radioembolization for hepatocellular carcinoma patients.经 Tc-巨聚合白蛋白 SPECT/CT 测量的 CT 纹理特征和肺分流分数,用于肝癌患者经动脉放射性栓塞治疗前。
Sci Rep. 2023 Dec 15;13(1):22288. doi: 10.1038/s41598-023-49787-7.
8
Prevalence of different LI-RADS v2018 categories in high-risk patients undergoing CT- or MRI-based screening for hepatocellular carcinoma.LI-RADS v2018 不同类别在接受基于 CT 或 MRI 的肝细胞癌筛查的高危患者中的流行情况。
Abdom Radiol (NY). 2023 Dec;48(12):3696-3702. doi: 10.1007/s00261-023-04040-7. Epub 2023 Sep 19.
9
Estimating postsurgical outcomes of patients with a single hepatocellular carcinoma using gadoxetic acid-enhanced MRI: risk scoring system development and validation.使用钆塞酸增强 MRI 评估单个肝细胞癌患者的术后结果:风险评分系统的开发和验证。
Eur Radiol. 2023 May;33(5):3566-3579. doi: 10.1007/s00330-023-09539-7. Epub 2023 Mar 18.
10
Utilization of a Machine Learning Algorithm for the Application of Ancillary Features to LI-RADS Categories LR3 and LR4 on Gadoxetate Disodium-Enhanced MRI.利用机器学习算法将辅助特征应用于钆塞酸二钠增强MRI上的LI-RADS分类LR3和LR4
Cancers (Basel). 2023 Feb 21;15(5):1361. doi: 10.3390/cancers15051361.